Validation of the Setswana Translated Quality of Recovery Questionnaire in Orthopaedic Patients at a Tertiary Hospital in South Africa

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSefako Makgatho Health Sciences University

About this trial

This observational study aims to evaluate the validity, reliability and feasibility of the Setswana-translated version of the 15-item Quality of Recovery (QoR-15) questionnaire. The question it aims to answer is:

Does the Setswana translation of the QoR-15 serve as a valid, reliable and user friendly tool for assessing postoperative recovery in Setswana speaking patients undergoing orthopaedic surgery at a tertiary hospital in Gauteng, South Africa?

The participants will be asked to complete the Setswana-translated QoR-15 questionnaire both preoperatively and postoperatively.

In addition, they will be asked to rate their overall postoperative recovery using a visual analog scale (VAS).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients over 18 years of age

Scheduled elective orthopaedic surgery at Dr George Mukhari Academic Hospital

Disqualifiers

Patients who are not fluent in Setswana

Patients booked for emergency surgery where a delay to surgery could be detrimental.

Patients where the surgery is delayed beyond 10 days of the initial assessment and pre-operative QoR-15 measurement.

Patients with a psychiatric disturbance that precludes complete co-operation.

Trial population

The study population will consist of adult patients (aged 18 years and older) who are fluent in Setswana and are scheduled for elective orthopaedic surgery at the hospital. The population is expected to be diverse in terms of gender, age, and socioeconomic background, reflecting the typical demographic of Setswana-speaking patients. These patients are expected to be conscious and alert in the postoperative period, able to provide informed consent, and cognitively capable of understanding and responding to a questionnaire. Participants with known cognitive impairments, severe postoperative complications that impair communication, or those unwilling to participate will be excluded.

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Convergent validity of the Setswana-translated QoR-15 score

To evaluate convergent validity by assessing the Spearman correlation between the Setswana-translated QoR-15 score and a general visual analog scale (VAS). Unit of measure: Correlation co-efficient (r).

Time frame
Pre-operative baseline and 24 hours postoperatively.

Secondary outcomes

1

Construct validity of the Setswana-translated QoR-15 score

To evaluate construct validity by assessing associations between the QoR-15 score and patient factors (age, gender, duration \& severity of surgery). Unit of Measure: Regression coefficients/association statistics

Time frame
Pre-operative (baseline) and 24 hours postoperatively
2

Internal consistency of the Setswana translated QoR-15 score

To evaluate internal consistency using Cronbach's alpha based on the average correlation between the QoR-15 items.

Time frame
Pre-operative (baseline) and 24 hours postoperatively
3

Test-retest variability of the Setswana-translated QoR-15 score

To evaluate test-retest variability in a subset of 25 patients who will be asked to complete a repeat assessment 60 minutes after their first postoperative questionnaire. Unit of measure: intraclass correlation coefficient

Time frame
60 minutes after first postoperative questionnaire
4

Acceptability and feasibility of the Setswana-translated QoR-15 score

To evaluate acceptability and feasibility by calculating the recruitment rate, completion rate and time taken to complete the questionnaire

Time frame
During recruitment and postoperative assessment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: